The ERCC2 gene Lys751Gln and Asp312Asn SNP have been shown to correlate with a diminished response to cisplatin-based chemotherapy or radiotherapy in patients with head and neck cancer (45). The gene discussed is ERCC2; the disease is head and neck cancer.